A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)
Refractory Chronic Cough
About this trial
This is an interventional treatment trial for Refractory Chronic Cough
Eligibility Criteria
Inclusion Criteria: Capable of giving signed informed consent Refractory chronic cough (including unexplained chronic cough) for at least one year Women of child-bearing potential must use a highly effective contraception method during the study and for at least 14 days after the last dose Exclusion Criteria: Current smoker/vaper (all forms of smoking and inhaled substances, including , cannabis/tobacco smoke and nicotine vapors) or individuals who have given up smoking within the past 6 months, or those with >20 pack-year smoking history Diagnosis of Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis, idiopathic pulmonary fibrosis or uncontrolled asthma Respiratory tract infection within 4 weeks before screening Laboratory confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection at screening History of malignancy in the last 5 years History of alcohol or drug abuse within the last 3 years Has a positive serologic test for human immunodeficiency virus (HIV), hepatitis B virus surface antigen, or hepatitis C virus. Previous participation in a BLU-5937 trial
Sites / Locations
- G & L Research, LLCRecruiting
- Phoenix Medical Research Institute, LLC
- California Allergy & Asthma Medical Group Inc.Recruiting
- Southern California Institute For Respiratory Diseases, Inc.Recruiting
- Paradigm Clinical Research Centers, Inc.Recruiting
- Precision Research Institute, LLCRecruiting
- Allergy & Asthma Associates of Santa Clara ValleyRecruiting
- Colorado Allergy and Asthma Centers, PCRecruiting
- Clinical Site Partners, LLC d/b/a CSP LeesburgRecruiting
- Savin Medical Group LLCRecruiting
- Destin Pulmonary Critical Care, PLLS.Recruiting
- Lenus Research & Medical GroupRecruiting
- In-Quest Medical Research, LLCRecruiting
- The Iowa Clinic, PCRecruiting
- Minnesota Lung CenterRecruiting
- Mayo Clinic - RochesterRecruiting
- Minnesota Lung CenterRecruiting
- The Clinical Research Center, LLCRecruiting
- Creighton UniversityRecruiting
- ActivMed Practices & Research, LLCRecruiting
- PMG Research of Charlotte, LLCRecruiting
- Clinical Research of GastoniaRecruiting
- AccellacareRecruiting
- Bernstein Clinical Research Center, LLC
- Cleveland Clinic
- Optimed Research, LTDRecruiting
- Geisinger Medical Center
- Pharmacorp Clinical Trials, Inc.Recruiting
- Clinical Trials Center of Middle TennesseeRecruiting
- Houston Pulmonary, Sleep, Allergy and Asthma AssociatesRecruiting
- Quality Assurance Research CenterRecruiting
- AMR Norfolk, Formerly Tidewater Associates, an AMR CompanyRecruiting
- Northside HealthRecruiting
- John Hunter Hospital
- Lung Research QLD Pty LtdRecruiting
- The Prince Charles HospitalRecruiting
- Royal Adelaide Hospital
- Institute for Respiratory Health IncRecruiting
- TrialsWestRecruiting
- MUDr. I. Cierna Peterova s.r.o.Recruiting
- Fakultni nemocnice BrnoRecruiting
- MUDr. Otakar Hokynar plicni ordinaceRecruiting
- Plicni ambulance - MUDr. Ilona PavlisovaRecruiting
- DAWON spol. s.r.o.Recruiting
- MUDr. Jaroslav Mares - TBC a respir. nemociRecruiting
- Thoraxklinik Heidelberg gGmbH
- Pneumologische Praxis PasingRecruiting
- Lungenzentrum DarmstadtRecruiting
- Studienzentrum MaingauRecruiting
- Klinikum der Johann Wolfgang Goethe-Universitaet
- Medaimun GmbHRecruiting
- Zentrum fuer ambulante pneumologische Forschung Marburg GbRRecruiting
- Ballenberger Freytag Wenisch Institut für klinische Forschung
- Pneumologicum HalleRecruiting
- Pneumologisches Forschungsinstitut Hohegeest GbRRecruiting
- PRI Pulmonary Research Institute
- KLB Gesundheitsforschung Luebeck GmbHRecruiting
- Charité Universitaetsmedizin Berlin - Campus Charité Mitte
- Arztezentrum in der Axel-Springer-PassageRecruiting
- Government Hospital for Chest and Communicable Diseases
- Sarvodya Hospital
- K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre
- Shree Hospital and Critical Care Centre
- Assured Care Plus Hospital
- W. Pratiksha Hospital
- Yonsei University Wonju Severance Christian HospitalRecruiting
- Seoul National University Bundang HospitalRecruiting
- Jeonbuk national university hospitalRecruiting
- Pusan National University HospitalRecruiting
- The Catholic University of Korea, Incheon St. Mary's HospitalRecruiting
- Seoul National University HospitalRecruiting
- The Catholic University of Korea, Eunpyeong St. Mary's HospitalRecruiting
- Severance Hospital, Yonsei University Health SystemRecruiting
- Konkuk University Medical CenterRecruiting
- Asan Medical CenterRecruiting
- Samsung Medical CenterRecruiting
- The Catholic University of Korea, Seoul St. Mary's HospitalRecruiting
- Korea University Guro HospitalRecruiting
- Waitemata Clinical ResearchRecruiting
- Christchurch Hospital NZRecruiting
- Pacific Clinical Research Network - ForteRecruiting
- Dunedin HospitalRecruiting
- Waikato HospitalRecruiting
- Pacific Clinical Research Network - RotoruaRecruiting
- Alian s.r.o.Recruiting
- Nemocnica s poliklinikou Sv. Jakuba, n.o. BardejovRecruiting
- Zeleznicna nemocnica s poliklinikouRecruiting
- PNEUMO-MED s.r.o.Recruiting
- Plucna ambulancia Hrebenar, s.r.o.Recruiting
- Changhua Christian Medical Foundation Changhua Christian HospitalRecruiting
- Kaohsiung Medical University Chung-Ho Memorial HospitalRecruiting
- E-DA HospitalRecruiting
- Chang Gung Memorial Hospital,LinkouRecruiting
- Castle Hill Hospital
- Broomfield Hospital
- King's College Hospital
- Accellacare NorthamptonshireRecruiting
- North Tyneside General Hospital
- Accellacare WarwickshireRecruiting
- Ormeau Clinical Trials Ltd
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
BLU-5937 25 mg
BLU-5937 50 mg
Placebo
BLU-5937 oral dose 25 mg twice a day.
BLU-5937 oral dose 50 mg twice a day.
Matching Placebo for BLU-5937 oral dose twice a day.